The board in its meeting held on May 6, 2025 has approved the audited financial results for the quarter and year ended march 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 1.8 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
National Peroxide Limited reported its audited results for FY25 with revenue from operations falling to ₹28,687 lakhs from ₹33,299 lakhs in FY24, a decline of about 14%. Profit after tax collapsed by roughly 82% to ₹307 lakhs (from ₹1,679 lakhs), and EPS dropped sharply from ₹29.22 to ₹5.35. The Q4 quarter standalone was particularly weak, posting a loss after tax of ₹649 lakhs against a profit of ₹225 lakhs in the year-ago quarter, though prior year tax adjustments provided some cushion. The statutory auditor Kalyaniwalla & Mistry LLP issued an unmodified (clean) opinion on the results. The board also appointed Parikh & Associates as Secretarial Auditor for a five-year term from FY26 to FY30, subject to shareholder approval.
Sharp drop in full-year profitability despite revenue holding up reasonably signals significant margin pressure for shareholders. The weak Q4 loss and shrinking bottom line may weigh on the stock, though the clean audit opinion and absence of debt concerns provide some reassurance. Investors should watch whether margin recovery materialises in coming quarters.